Citation: Gw. Waterer et al., Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations, AM J R CRIT, 163(7), 2001, pp. 1599-1604
Authors:
Rubinstein, E
Cammarata, SK
Oliphant, TH
Wunderink, RG
Citation: E. Rubinstein et al., Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenterstudy, CLIN INF D, 32(3), 2001, pp. 402-412
Citation: Gw. Waterer et Rg. Wunderink, The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures, RESP MED, 95(1), 2001, pp. 78-82
Citation: Rg. Wunderink et Gw. Waterer, Severe community-acquired pneumonia - The need to customize empiric therapy, CHEST, 120(4), 2001, pp. 1053-1055
Citation: Gw. Waterer et al., Legionella and community-acquired pneumonia: A review of current diagnostic tests from a clinician's viewpoint, AM J MED, 110(1), 2001, pp. 41-48
Citation: Gw. Waterer et al., Bronchostenosis due to childhood tuberculosis and manifested as an asymptomatic mass, SOUTH MED J, 93(11), 2000, pp. 1102-1104
Citation: Gw. Waterer et al., Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy, CHEST, 118(6), 2000, pp. 1839-1840
Citation: Gw. Waterer et al., Bacteremic community-acquired pneumonia in an immunocompetent adult due toBurkholderia cepacia, CHEST, 116(6), 1999, pp. 1842-1843
Authors:
George, DL
Falk, PS
Wunderink, RG
Leeper, KV
Meduri, GU
Steere, EL
Corbett, CE
Mayhall, CG
Citation: Dl. George et al., Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling, AM J R CRIT, 158(6), 1998, pp. 1839-1847